Health ❯Healthcare ❯Patient Safety

Adverse Events

Overdose Risks Self-Administration Risks Monitoring Systems Serious Adverse Events Acute Liver Injury Liver Failure Clinical Protocols Gastrointestinal Events Vaccination Guidelines Medication Complications

Amgen Advances Monthly Obesity Drug to Phase 3 After 20% Weight Loss in Mid-Stage Trial

Amgen plans to use lower starting doses with gradual escalation to improve tolerability ahead of expanded Phase 3 studies

Sarepta Halts Elevidys Shipments for Non-Ambulatory Patients After Second Fatal Liver Failure

FDA Halts Rocket’s RP-A501 Gene Therapy for Danon Disease After Patient’s Death

Abortion Pill Study Fuels Debate Over Safety and Access

French Authorities Exclude Seniors from Chikungunya Vaccination After Serious Adverse Events

First Death Reported from Sarepta's Duchenne Gene Therapy Raises Safety Concerns

Scotland Faces Health Crisis Linked to Weight-Loss Injections

FDA Issues Warning on Overdoses from Compounded Semaglutide Injections